NCT06171698

Brief Summary

Prospectively measure impedance during cardiac catheterization to build a cardiac output algorithm.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Mar 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 30, 2023

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 28, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

December 15, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 24, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 24, 2025

Completed
Last Updated

July 14, 2025

Status Verified

July 1, 2025

Enrollment Period

2.2 years

First QC Date

November 28, 2023

Last Update Submit

July 9, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Feasibility of a non-invasive monitoring device

    Feasibility of a non-invasive monitoring device that can accurately measure cardiac output in patients with congenital heart disease as determined by percent error compared to catheter-measured cardiac output.

    From device placement to removal, up to 12 hours

Study Arms (1)

Research Prototype Monitor

EXPERIMENTAL
Device: Research Prototype Monitor

Interventions

Continuous vital sign is collected via a research prototype monitor

Research Prototype Monitor

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Scheduled to undergo cardiac catheterization with cardiac output measurement and Fick
  • Planned to undergo general anesthesia for cardiac catheterization standard of care
  • Parent/Guardian able to provide informed consent

You may not qualify if:

  • Not planned for standard of care general anesthesia for cardiac catheterization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Children's Center

Baltimore, Maryland, 21287, United States

Location

MeSH Terms

Conditions

Heart Defects, Congenital

Condition Hierarchy (Ancestors)

Cardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Danielle Gottlieb Sen, MD, MPH

    Johns Hopkins School of Medicine

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2023

First Posted

December 15, 2023

Study Start

March 30, 2023

Primary Completion

June 24, 2025

Study Completion

June 24, 2025

Last Updated

July 14, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations